Compare IDEXX Laboratories, Inc. (IDXX) vs Ross Stores, Inc. (ROST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Ross Stores, Inc. — how do they compare? IDEXX Laboratories, Inc. trades at $519.54 (market cap $40.43B), while Ross Stores, Inc. trades at $222.86 (market cap $71.94B). The key difference: Ross Stores, Inc. is the larger of the two by market cap, and Ross Stores, Inc. pays a 0.79% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and Ross Stores, Inc. for 48 Days on average.
| IDXX | ROST | |
|---|---|---|
Market Cap | $40.43B | $71.94B |
Volume | 692,164 | 2,002,519 |
Sector | Health | Consumer Cyclical |
52-Week High | $766.68 | $255.23 |
52-Week Low | $504.70 | $147.71 |
Typical Hold Time | 46 Days | 48 Days |
Enterprise Value | $41.32B | $72.39B |
Dividend Yield | — | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $519.87, up 2.61% on the day, with a bearish technical signal from moving averages but strong fundamentals including a 25.03% net income margin and consistent earnings beats. Revenue grew to $4.3B in 2025, and the company recently acquired CoVetAI to enhance veterinary workflow intelligence, signaling strategic expansion.
The stock's outlook is supported by robust profitability and analyst consensus, but faces headwinds from technical weakness and potential market volatility. With a $665 price target implying significant upside, the primary risks include competitive pressures and execution of growth initiatives amid economic uncertainties.
Ross Stores (ROST) trades at $222.41, down 1.38% amid broader market weakness. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability metrics including 42.63% ROE and 10.85% net margin. Technical indicators signal bearish momentum with the price near key support at $221, while analyst consensus remains bullish with a $274.14 price target. Recent news highlights store expansion initiatives and strong closeout supply positioning the company for growth.
ROST presents a compelling investment case with strong operational performance and analyst confidence, though near-term technical weakness and competitive pressures warrant caution. The 16% upside to consensus target offers potential reward, but investors should monitor execution of expansion plans and consumer spending trends given the bearish technical signals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Ross Stores, Inc.
Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →
